Academic Journal

Insulin exocytosis in Goto-Kakizaki rat β-cells subjected to long-term glinide or sulfonylurea treatment

التفاصيل البيبلوغرافية
العنوان: Insulin exocytosis in Goto-Kakizaki rat β-cells subjected to long-term glinide or sulfonylurea treatment
المؤلفون: Kawai, Junko, Ohara-Imaizumi, Mica, Nakamichi, Yoko, Okamura, Tadashi, Akimoto, Yoshihiro, Matsushima, Satsuki, Aoyagi, Kyota, Kawakami, Hayato, Watanabe, Takashi, Watada, Hirotaka, Kawamori, Ryuzo, Nagamatsu, Shinya
المصدر: Biochemical Journal ; volume 412, issue 1, page 93-101 ; ISSN 0264-6021 1470-8728
بيانات النشر: Portland Press Ltd.
سنة النشر: 2008
الوصف: Sulfonylurea and glinide drugs display different effects on insulin granule motion in single β-cells in vitro. We therefore investigated the different effects that these drugs manifest towards insulin release in an in vivo long-term treatment model. Diabetic GK (Goto-Kakizaki) rats were treated with nateglinide, glibenclamide or insulin for 6 weeks. Insulin granule motion in single β-cells and the expression of SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein receptor) proteins were then analysed. Perifusion studies showed that decreased first-phase insulin release was partially recovered when GK rats were treated with nateglinide or insulin for 6 weeks, whereas no first-phase release occurred with glibenclamide treatment. In accord with the perifusion results, TIRF (total internal reflection fluorescence) imaging of insulin exocytosis showed restoration of the decreased number of docked insulin granules and the fusion events from them during first-phase release for nateglinide or insulin, but not glibenclamide, treatment; electron microscopy results confirmed the TIRF microscopy data. Relative to vehicle-treated GK β-cells, an increased number of SNARE clusters were evident in nateglinide- or insulin-treated cells; a lesser increase was observed in glibenclamide-treated cells. Immunostaining for insulin showed that nateglinide treatment better preserved pancreatic islet morphology than did glibenclamide treatment. However, direct exposure of GK β-cells to these drugs could not restore the decreased first-phase insulin release nor the reduced numbers of docked insulin granules. We conclude that treatment of GK rats with nateglinide and glibenclamide varies in long-term effects on β-cell functions; nateglinide treatment appears overall to be more beneficial.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1042/bj20071282
الاتاحة: https://doi.org/10.1042/bj20071282
https://portlandpress.com/biochemj/article-pdf/412/1/93/651828/bj4120093.pdf
رقم الانضمام: edsbas.4EFD12A
قاعدة البيانات: BASE